Apr 10, 2026 06:06AM
Apr 7, 2026 02:57AM
Apr 6, 2026 04:02PM
Apr 6, 2026 01:59PM
Apr 6, 2026 07:11AM
Apr 6, 2026 07:07AM
Apr 6, 2026 07:01AM Neurocrine to acquire Soleno Therapeutics for $2.9 billion in cash deal
Apr 6, 2026 07:00AM
Feb 25, 2026 04:01PM
Nov 4, 2025 04:01PM
Oct 22, 2025 08:00AM
Oct 13, 2025 08:00AM
Oct 13, 2025 08:00AM
Aug 6, 2025 04:04PM Soleno Therapeutics reports early commercial traction for VYKAT XR
Aug 6, 2025 04:01PM
May 7, 2025 04:02PM
May 7, 2025 04:01PM
Feb 27, 2025 04:05PM
Nov 6, 2024 04:05PM
Aug 15, 2024 08:01AM
Aug 15, 2024 08:00AM Soleno Therapeutics Announces Updates to its Board of Directors
Aug 7, 2024 04:05PM
May 9, 2024 04:05PM
Mar 6, 2024 04:05PM
Jan 24, 2024 08:01AM
Jan 24, 2024 08:00AM
Nov 7, 2023 08:00AM
Aug 8, 2023 04:05PM Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
May 9, 2023 04:05PM
Mar 21, 2023 04:05PM
Nov 9, 2022 04:05PM
Aug 10, 2022 04:05PM
May 10, 2022 04:01PM
Mar 31, 2022 04:05PM
Nov 10, 2021 04:05PM Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
May 5, 2021 04:01PM
Mar 8, 2021 09:32AM
Mar 3, 2021 04:01PM
Nov 10, 2020 04:01PM
Aug 10, 2020 04:01PM
Jun 24, 2020 09:31AM
May 12, 2020 04:01PM Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
Mar 4, 2020 04:05PM
Dec 23, 2019 08:44AM
Nov 13, 2019 08:00AM
Aug 7, 2019 04:05PM
May 13, 2019 08:00AM
Apr 29, 2019 08:06AM
Apr 29, 2019 08:00AM Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
Mar 18, 2019 08:00AM

1,158,097 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All